They’re Back – Will We See the M&A Boon? Hatteras White Paper on Biotech M&A
By: Clay Thorp, General Partner, Hatteras Venture Partners Michael Yee of Jefferies is one of the best analysts in biotech, and he knows his… Read More
Qvella FAST System and FAST-PBC Prep Cartridge Get CE Marked and FDA Listed for In Vitro Diagnostic Use
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current… Read More
Huma.AI Adds Post-Market Surveillance Capacity to its Unique AI-Based Healthcare Data Knowledge Platform
Company also secures $9.5 million in Series A funding to expand its resources to meet rapidly growing customer demand PALO ALTO, Calif.–(BUSINESS… Read More
Aledade Acquires Advance Care Planning Company Iris Healthcare as Part of New Health Services Arm
Acquisition Enables Company to Provide More High-Value, Patient-Centered Services Through Its Network of More Than 1,000 Independent Primary Care Practices and Health Centers Bethesda, Md. Read More
VIGIL NEUROSCIENCE ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia… Read More
Tune Therapeutics Debuts with $40 Million to Fine-Tune the Human Genome
A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40 million in new funding and a leadership team peppered with… Read More
Morgan Stanley Expansion Capital and Ally Bridge Group Lead $135 Million Investment in Elligo
Proceeds Used to Acquire ClinEdge and Invest Further in Technology & Data Platform SAN FRANCISCO–(BUSINESS WIRE)– Morgan Stanley Expansion Capital and Ally Bridge Group,… Read More
Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases
First Indication for Lead TREM2 Agonist Program Announced as Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Financing Led by Vida Ventures; Stefan… Read More
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally… Read More
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic Stroke MIAMI, June 23, 2021 (GLOBE NEWSWIRE) — RapidPulse,… Read More